Healthcare provider profile · identity verified

Michael Maharry, MD

Family Practice · IOWA CITY, IA · NPI 1073509436

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	173
Amlodipine Besylate	Amlodipine Besylate	364	105
Levothyroxine Sodium	Levothyroxine Sodium	244	73
Lisinopril	Lisinopril	215	69
Omeprazole	Omeprazole	208	61
Tramadol Hcl	Tramadol Hcl	158	24
Losartan Potassium	Losartan Potassium	147	40
Albuterol Sulfate Hfa	Albuterol Sulfate	146	48
Hydrochlorothiazide	Hydrochlorothiazide	141	43
Gabapentin	Gabapentin	127	31
Metformin Hcl	Metformin Hcl	120	39
Metoprolol Succinate	Metoprolol Succinate	111	26
Metformin Hcl Er	Metformin Hcl	99	27
Pioglitazone Hcl	Pioglitazone Hcl	98	21
Glipizide Er	Glipizide	97	21
Trazodone Hcl	Trazodone Hcl	97	25
Famotidine	Famotidine	91	28
Metoprolol Tartrate	Metoprolol Tartrate	89	25
Tamsulosin Hcl	Tamsulosin Hcl	86	31
Mounjaro	Tirzepatide	85	16
Fluticasone Propionate	Fluticasone Propionate	80	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	15
Pantoprazole Sodium	Pantoprazole Sodium	80	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	19
Furosemide	Furosemide	70	28
Warfarin Sodium	Warfarin Sodium	70	16
Rosuvastatin Calcium	Rosuvastatin Calcium	68	24
Duloxetine Hcl	Duloxetine Hcl	67	19
Potassium Chloride	Potassium Chloride	67	20
Allopurinol	Allopurinol	66	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	14
Montelukast Sodium	Montelukast Sodium	63	14
Simvastatin	Simvastatin	58	21
Ozempic	Semaglutide	55	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	suppressed
Alprazolam	Alprazolam	54	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	12
Enalapril Maleate	Enalapril Maleate	52	15
Ventolin Hfa	Albuterol Sulfate	52	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	13
Eliquis	Apixaban	49	suppressed
Meloxicam	Meloxicam	47	15
Baclofen	Baclofen	45	suppressed
Ibuprofen	Ibuprofen	44	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	16
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Chlorthalidone	Chlorthalidone	43	11
Trulicity	Dulaglutide	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	suppressed
Bupropion Xl	Bupropion Hcl	42	12
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Atenolol	Atenolol	39	13
Benazepril Hcl	Benazepril Hcl	38	suppressed
Finasteride	Finasteride	38	suppressed
Ketoconazole	Ketoconazole	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	13
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	16
Ezetimibe	Ezetimibe	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Celecoxib	Celecoxib	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Prednisone	Prednisone	23	17
Nifedipine Er	Nifedipine	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Glipizide	Glipizide	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Acarbose	Acarbose	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Invokana	Canagliflozin	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Azithromycin	Azithromycin	13	13
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Primidone	Primidone	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error